The CB5005 sequence can be divided into two segments, and the peptide itself, therefore, exhibits dual functions in cell membrane penetration and as a nuclear factor kappa light chain enhancer of activated B cell (NF-κB) inhibition, which can lead to suppressed tumor growth and higher sensitivity of tumor cells to chemotherapeutics. The gene discussed is NFKB1; the disease is neoplasm.